T

TriSalus Life Sciences Inc
NASDAQ:TLSI

Watchlist Manager
TriSalus Life Sciences Inc
NASDAQ:TLSI
Watchlist
Price: 4.06 USD
Market Cap: 123.8m USD
Have any thoughts about
TriSalus Life Sciences Inc?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

-2.5
Current
-28.6
Median
11.3
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-2.5
=
Enterprise Value
134.1m USD
/
EBITDA
-53.6m USD
All Countries
Close
EBITDA Growth EV/EBITDA to Growth
US
T
TriSalus Life Sciences Inc
NASDAQ:TLSI
Average EV/EBITDA: 95.4
Negative Multiple: -2.5
N/A N/A
CA
A
Advance Lithium Corp
XTSX:AALI
Negative Multiple: -862 467.7 N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
29%
N/A
US
Coupang Inc
F:788
51.2
266%
0.2
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
27.5
N/A N/A
US
R
Reddit Inc
NYSE:RDDT
Negative Multiple: -47.2 N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
64%
N/A
IN
Jio Financial Services Ltd
NSE:JIOFIN
207.5
N/A N/A
ZA
F
Fortress Real Estate Investments Ltd
JSE:FFB
Not Available
69%
N/A
ZA
R
Resilient Reit Ltd
JSE:RES
Not Available
69%
N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-4.6
2-Years Forward
EV/EBITDA
-17.8
3-Years Forward
EV/EBITDA
-12.4

See Also

Discover More